Taysha Gene Therapies, Inc. (TSHA) Revenue History
Taysha Gene Therapies, Inc. (TSHA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | $2.50M |
| 2023-12-31 | $15.45M |
| 2024-12-31 | $8.33M |
| 2025-12-31 | $9.77M |
How TSHA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NMTC | NeuroOne Medical Technologies Corporation | $9.10M |
| ACRS | Aclaris Therapeutics Inc. | $7.83M |
| HSDT | Helius Medical Technologies Inc. | $6.02M |
| ABEO | Abeona Therapeutics Inc. | $5.82M |
| ACHV | Achieve Life Sciences Inc. | $5.06M |
These are five companies in the same sector as TSHA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Taysha Gene Therapies, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("TSHA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | TSHA | $5.99 | -6.48% | 2.18M |
| 3 | ||||
| 4 | ||||
| 5 |